The erythrocytes from a patient with Scott syndrome, a bleeding disorder characterized by an isolated defect in expression of platelet procoagulant activity, have been studied. When incubated with the calcium ionophore A23187, Scott syndrome red blood cells (RBCs) expressed less than 10% of the prothrombinase (enzyme complex of coagulation factors Va and Xa) activity of A23187-treated RBCs obtained from normal controls. Consistent with the results from enzyme assay, the ionophore-treated Scott syndrome erythrocytes exhibited diminished membrane vesiculation and decreased exposure of membrane binding sites for factor Va compared with identically treated controls. When examined by scanning electron microscopy, untreated Scott syndrome RBCs were indistinguishable from normal cells. After incubation with A23187, however, the morphology of Scott syn-ALCIUM INFLUX initiates a variety of cellular re-C sponses. In blood platelets and red blood cells (RBCs), these responses include marked shape changes with evagination of the cell surface and the shedding of small membrane vesicles or "microparticles" from the plasma membrane.'.' The formation of these microparticles, which involves fusion between apposing segments of plasma membrane, may be accompanied by a local collapse of the normal asymmetric distribution of plasma membrane phospholipids,' particularly if the aminophospholipid translocase (which restores phospholipid asymmetry by specifically translocating phosphatidylserine and other aminophospholipids to the membrane inner leaflet) is inhibited.' Loss of 
drome RBCs contrasted markedly from normal erythrocytes. Whereas the Ca2+ ionophore induced marked echinocytosis and spiculation of normal RBCs, Scott syndrome RBCs remained mostly discoid under these conditions, with only an occasional echinocyte-like cell observed. These aberrant responses t o intracellular Ca'+ were also observed for resealed ghosts prepared from Scott syndrome erythrocytes, indicating that they are related to a defect in the membrane or membrane-associated cytoskeleton. The finding that the erythrocytes of this patient share many of the membrane abnormalities reported previously for Scott syndrome platelets suggests that this defect is common t o both cell lines and involves a membrane component required for vesicle formation and for expression of prothrombinase sites.
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plasma membrane phospholipid asymmetry leads to exposure of phosphatidylserine at the outer surface, which can promote assembly on the membrane of two enzymesubstrate complexes of the coagulation cascade, the tenase complex and the prothrombinase complex. 6 In the tenase reaction, the pro-enzyme factor X is activated to factor Xa by a complex of the enzyme factor IXa and its cofactor protein, VIIIa. In the prothrombinase reaction, prothrombin is converted to thrombin by a complex of the enzyme factor Xa and its cofactor protein, factor Va. Membrane assembly of these complexes dramatically enhances the rate of thrombin formation, accounting for the procoagulant activity of activated platelets.' Calcium ionophore-induced shedding of microparticles from the RBC membrane also leads to the surface exposure of phosphatidylserine and to the expression of membrane procoagulant activity, although this change in RBCs occurs more slowly and to a lesser extent than in platelets. ' In 1979, Weiss et a18 described a patient with a rare bleeding disorder associated with an isolated deficiency of platelet procoagulant activity, presently referred to as Scott syndrome.' Upon activation, these platelets were reported to have considerably decreased binding sites for factor Va"' and factor VIIIa." Moreover, we recently showed that, in response to various agonists, these platelets were markedly deficient in their ability to support both tenase and prothrombinase activity, showed a decreased surface exposure of plasma membrane phosphatidylserine, and were markedly impaired in their capacity to generate microparticIe~.~.'* In view of the normal capacity of RBCs to shed membrane vesicles and to express a procoagulant surface upon Ca2+ influx, we have examined these phenomena in erythrocytes obtained from the patient with Scott syndrome described above. The present study shows that the aberrant membrane-related phenomena observed in this patient's platelets are also evident in the patient's RBCs as well as in resealed ghosts prepared from these RBCs.
Scanning electron microscopy. RBCs or resealed red ghosts at 108/mL were fixed by incubation for 30 minutes in HEPESbuffered saline containing 1% glutaraldehyde. Samples were diluted 20-fold into 25% ethanol. After centrifugation (12,00Og, 4 minutes), the pellet was resuspended to lO"/mL in absolute ethanol. Cells were deposited on plastic cover slips, air-dried, and sputter-coated with gold. Scanning electron micrographs were made using a Philips CM-12 electron microscope at 15 kV (Phillips, Eindhoven, The Netherlands).
Fluorescence-gated flow cytometry of RBCs and RBC-derived microparticles was performed by modification of methods previously described for platelets.',' Washed RBCs (2.5 x lo6) were incubated (10 minutes, 23°C) in a total volume of 30 pL HEPES-buffered saline containing 2 pg/mL factor Va light chain and 0.1% albumin. Five microliters of FITC-V237 was then added (final IgG concentration, 30 kg/mL) and the cells incubated an additional 20 minutes in the dark. The samples were then diluted to 1 mL in HEPES-buffered saline, and stained by addition of 5 pL of the lipophilic fluorescent dye, DilC16(3) (final concentration, 100 nmol/L; delivered in ethanol). The DilC16(3)-positive RBCs and microparticles were then analyzed within 30 minutes using a Becton Dickinson FACSCAN flow cytometer formatted for two-color analysis (Becton Dickinson, Mountain View, CA), with compensation for spillover of fluorescence between channels measuring FITC fluorescence (520 nm) and DilC16(3) fluorescence (585 nm). The light scatter and fluorescence channels were set at logarithmic gain. To resolve RBC-derived microparticles from background light scatter, acquisition was gated so as to include only those particles distinctly positive for DilC16(3) using a fluorescence lower limit threshold on the 585-nm channel that excluded background scatter. Five thousand DilC16(3)-positive particles were analyzed for forward and right-angle light scatter (to discriminate RBCs and microparticles) and for FITC fluorescence intensity (to detect membrane-bound factor Va light chain). Background fluorescence due to nonspecific binding of FITC-V237 to RBCs and to RBC microparticles was determined using samples that were identically treated, omitting factor Va light chain. To confirm that the small scattering particles detected when DilC16(3) fluorescence was used to threshold acqu on represented vesicles derived from the erythrocyte membrane, RBCs (and RBC membrane-derived microparticles) were also stained for flow cytometry with a FITC-labeled antibody against glycophorin A (FITC-antiglycophorin A). The RBCs were first incubated with 40 pg/mL FITC-anti-glycophorin A (omitting FITC-V237) to label glycophorin A on the RBC (and microparticle) membrane, before dilution to 1 mL for analysis. Acquisition was then gated using a lower limit fluorescence threshold on the 520 nm channel (detecting FITC fluorescence) so as to include only glycophorin A-positive particles. The distribution of forward and right-angle light scatter of the glycophorin A-positive microparticles matched that detected when acquisition was gated on the fluorescence from DilC16(3).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of washed RBCs and gel-filtered platelets was performed by modification of methods previously de~cribed.'~ RBCs were incubated for 10 minutes at 37°C with either 0 or 5 kmol/L A23187 and then lysed at 0°C by 20-fold dilution in 20 mmol/L HEPES, 0.2 mmol/L EGTA, 1 mmol/L MgCl,, pH 7.4. The membranes were washed three times with this solution and then subjected to 7.5% PAGE under reducing conditions. Gel-filtered platelets (1 x 10"mL) were incubated for 10 minutes at 37°C with either 0 or 1 kmol/L A23187, before detergent solubilization for SDS-PAGE, exactly as described in Wiedmer et al.I4 Protein bands were visualized by staining with Coomassie brilliant blue. 
RESULTS
We have recently shown that erythrocytes treated with calcium ionophore acquire the ability to provide a catalytic surface for the prothrombinase enzyme c~m p l e x .~ This property correlates with increased exposure of phosphatidylserine at the outer surface of the RBCs as well as the membrane microparticles, which are vesiculated from the RBCs as the result of Caz+ influx. This process of Ca"-induced vesiculation and phosphatidylserine exposure required to form a procoagulant surface for the prothrombinase reaction has previously been shown to occur in platelets, and to be defective in the platelets of Scott ~y n d r o m e .~~~~'~ In an effort to determine if the prothrombinase defect observed for Scott syndrome is restricted to platelets or is also expressed by other blood cells, we examined the Ca2+ ionophore-induced prothrombinase activity of the RBCs obtained from this patient. As shown in p,mol/L) and for cells suspended in Caz+ concentrations up to 10 mmol/L (data not shown).
Scanning electron microscopy. It has been shown that normal RBCs treated with Ca'+ ionophore change shape from biconcave disks to distinctly smaller echinocytic ~pheres.'~'~ By contrast, upon treatment with Ca'+ ionophore, Scott syndrome RBCs mainly retained a biconcave shape, although the surface exhibited distinct ruffling and an occasional echinocyte-like cell was observed (Fig 2) . It should be noted that, in addition to retaining biconcave shape, the size of the patient's RBCs was not appreciably affected by ionophore treatment, and few protruding membrane blebs could be discerned compared with the distinctly smaller echinocytic spheres observed for similarly treated control RBCs (Fig 2e and f) .
In Scott syndrome platelets, diminished prothrombinase activity correlates with decreased agonistinduced microparticle formation and decreased expression of factor Va binding site^.'^'" To determine whether similar phenomena occur in Scott syndrome RBCs, microparticle formation and factor Va binding was assessed by fluorescence-gated flow cytometry. Figure 3 shows typical dot plots of forward-angle versus right-angle light scatter obtained for erythrocytes treated with Ca'+ ionophore. Incubation of normal erythrocytes with Caz+ ionophore induced two conspicuous changes in the scatter plots. First, the erythrocytes showed a prominent decrease in forward-angle scatter with upward shift in side scatter (Fig 3A and C) , presumably reflecting the changes is shape and size shown by electron microscopy (Fig 2a and c) . Second, there was an appreciable increase in the number of microparticles shed from the erythrocyte surface, which could be distinguished from the RBCs by their characteristic low forward-angle light scatter (particles in MP gate of Fig 3; see also below). These RBC-derived microparticles appear to approximate the size of platelet-derived microparticles (as determined by forward-angle light ~catter).'.~ In contrast to normal erythrocytes, Scott syndrome RBCs showed only minimal light scatter changes upon ionophore treatment, and diminished microvesiculation (Fig 3B and D) . Interpretation of the data of Fig 3 relating to the formation of RBC microparticles was based on the similarity of the light scattering properties of the glycophorin A-positive microparticles (particles in MP gate of Fig 3) that were detected after ionophore treatment of RBCs to that previously reported for platelet glycoprotein Ib-positive microparticles released from the surface of ionophore-treated platelets.' To confirm that the particles included in the MP gate of Fig  3 represent small vesicles shed from the RBC membrane, ionophore-treated RBCs were allowed to settle, and the forward-angle scatter of the cell-free supernatant was compared with the scatter of the original cell suspension (Fig 4) . These data show that the cell-free supernatants contain the low forward scattering particles ("microparticles") that are formed upon ionophore treatment of the RBCs (dashed curves, Fig 4) .
The exposure of factor Va binding sites on Scott syndrome RBCs and RBC-derived microparticles was evalu-
Flow cytometry.
For (Fig 1) .
It has been shown that erythrocyte ghosts resealed in the presence of Mg" and EGTA retain membrane phospholipid asymmetry, in contrast to ghosts rescaled in the prcsencc of Ca2+ ions." Moreover, upon treatment with Ca" ionophore, these resealed ghosts lose phospholipid asymmetry and show incrcased prothrombinase activity.'6 To determine whether thc aberrant response of Scott syndromc RBCs to influx of Caz+ reflects a defcct in thc erythrocyte "IbYdne itself (or its associated cytoskeleton), we prepared resealed ghosts (in the presence of Mg2+) and measured the gcneration of prothrombinase activity after the addition of Ca'+ ionophore. As can be seen in Fig 6, the defect in inducible prothrombinasc activity obscrved for Scott syndrome RBCs (sec Fig 1) is retained in thc ghosts derivcd from these cells. This phenomcnon was observed for both red ghosts (lysed and resealed to a 10% hemolysate) and for pink ghosts (lysed and resealed to a 2% hemolysate), suggesting that the aberrant response to Cazt observed in Scott syndrome RBCs is related to a membrane or membrane-associated component that is not lost upon dilution of the soluble hemolysate.
Inspection of calcium ionophore-treated resealed ghosts by scanning electron microscopy showed similar changes in morphology to those observed for the parent RBCs, including the maintenance of a generally biconcave shape by ionophore-treated Scott syndrome ghosts, as compared with the echinocytic transition of ionophore-treated ghosts derived from normal RBCs (Fig 7) .
Membraneproteins and Caz'-dependent proteolysis. Taken together, the results of Figs 6 and 7 suggest that the defect attributable to Scott syndrome RBCs reflects an aberrant property of the membrane or its associated cytoskeleton. Evidence has been presented that the cytoskeletal rearrangement normally observed upon influx of Ca2+ into the cytosol is related to a loss of cytoskeletal attachments to integral membrane proteins, including possible loss of these attachments through the proteolysis of constituents of the submembrane cytoskeleton by Ca2+-activated proteases (calpains) in the cytos01.~~'~~''~~~ As shown in Fig 8, evaluation by SDS-PAGE has to date shown no apparent abnormalities in composition of either platelets or erythrocyte membranes of Scott syndrome. Moreover, it is of interest that there were no appreciable differences detected in the ionophore-induced calpain activity (as detected by the proteolysis of cytoskeletal proteins) in Scott syndrome RBCs or platelets as compared with the ionophore-treated control cells (see Discussion).
DISCUSSION
The defective procoagulant response of Scott syndrome platelets has been shown to be associated with a defect in vesiculation of the platelet plasma membrane upon Caz+ influx, and is accompanied by decreased surface exposure of phosphatidylserine as well as decreased expression of membrane binding sites for factor Va.3,L0.'2 The defective expression of the procoagulant properties of this cell is observed despite normal secretion and aggregation responses to a variety of agonists.' It is now evident that the membrane phenomena underlying the Scott syndrome are not unique to platelets, but can also be shown in the CaZt ionophore-treated RBCs obtained from this patient. Because RBCs do not normally mobilize Ca" and this defect can be observed in both platelets and RBCs treated with a CaZc ionophore, it is apparent that Scott syndrome reflects an aberration in membrane function unrelated to the signal transduction pathways associated with Ca2' mobilization. The observation that the defect observed for the Scott syndrome RBC is equally apparent in resealed ghosts is consistent with the notion that the aberrant response of these cells originates with the plasma membrane or its associated cytoskeleton.
The mechanisms underlying microparticle formation, phosphatidylserine exposure, and expression of membrane prothrombinase sites in both platelets and RBCs remain poorly understood. In RBCs treated with Ca2+ ionophore, binding sites for factor Va are exposed on both shed microparticles and remnant cells (Fig 5 ) , and prothrombinase activity is found distributed on both membrane surface^.^ It remains to be determined whether these membrane sites €or factor Va binding and prothrombinase assembly become exposed when the RBC membrane evaginates into echinocytic spicules, during the membrane fusion event that is required for microvesicle formation, through subsequent adsorption of budded vesicles to the red cell surface, or through another process that is unrelated to membrane vesiculation. In Scott RBCs, the Caz+-induced response leading to exposure of procoagulant surface (Fig  l) , echinocyte formation (Fig 2) , and vesiculation (Fig 3) are all defective. The diminished number of factor Va binding sites that can be induced when these cells are treated with Ca2+ ionphore can be explained by decreased numbers of vesicles shed from the erythrocyte surface as well as diminished capacity of the membranes of both shed vesicles and remnant RBCs to bind factor Va (Fig 5) . Thus, it appears that the defective procoagulant response of Scott RBC is related to defective microvesicle formation as well as to diminished capacity of the shed microparticles and remnant cells to assemble the VaXa enzyme complex, phenomena that may or may not be causally interrelated. In both RBCs and platelets, membrane evagination and fusion required to shed vesicles from the cell surface appears to be initiated by influx of extracellular Caz*.'.14 However, the molecular events required to bring the inner plasma membrane surfaces together to initiate fusion and form the shed vesicle remain unresolved. Presumably, the events required for evagination and fusion entail cytoskeletal rearrangement as well as reorganization of the phospholipid bilayer at the fusion junction, including possible formation of a transient nonbilayer lipid structure."' In addition to membrane lipid, potential cellular constituents participating in this response include Ca" binding proteins of the membrane or membrane cytoskeleton, and Ca"-regulated enzymes required for proper membrane funcAt the present time we do not know whether the aberrant response to Ca" ionophore observed in the platelets and RBCs of this patient reflects a defect in or a deletion of thcse or other constituents of the cell membrane. To date, we have been unable to discern a conspicuous abnormality in either the phospholipid or membrane protein composition of the erythrocytes or platelets obtained from this patient (Fig 8 and Rosing et all') . Furthermore, under basal conditions, the asymmetric transbilayer distribution of phosphatidylserine in the plasma membrane of the Scott syndrome cells is normal. Our preliminary data also suggest that the activity of the aminophospholipid translocase that is required to establish this transbilayer asymmetry of phosphatidylserine"." is normal in Scott RBCs and platelets, and that this translocase activity is normally inhibited at elevated intracellular [Ca" ] (unpublished observations). This finding suggests that some other mechanism is responsible for the reduced surface exposure of phosphatidylserine and diminished expression of prothrombinase activity by Scott syndrome cells.
Although Scott syndrome erythrocytes exhibit no obvious abnormality in composition of cytoskeletal proteins, the remarkable ability of this patient's RBCs and resealed ghosts to retain a biconcave shape upon Ca" influx suggests an aberration in Ca''-regulated rearrangement of membrane cytoskeleton. In addition to calcium binding proteins, intracellular Ca"-dependent proteases have been suggested to play a role in phenomena related to cytoskeletal reorganization.s~l""' Our data, however, suggest that the calpain-mediated cleavage of these cytoskeletal proteins is not necessary for the Ca"-induced shedding of membrane microparticles?" nor implicated in the defective response of Scott syndrome blood cells (Fig 8) . Moreover, it can be anticipated that these enzymes are virtually absent in the resealed ghosts (prepared from cells lysed in EGTA), suggesting that calpain activity does not play a role in the disc-to-echinocyte transition observed in normal RBCs exposed to calcium ionophore, nor in the maintenance of the biconcave shape in ionophore-treated Scott syndrome RBCs. These data are consistent with the previous observations by Allan and Thomas'' that proteolysis of ankyrin and band 4.1 upon Ca" influx is not required for microvesiculation of normal RBCs to occur, and our observations that inhibition of intracellular calpains does not affect Ca2+-induced vesiculation of the platelet plasma membrane or the expression of platelet prothrombinase activity?I4 Therefore, it seems more likely that the aberration in Scott syndrome erythrocytes and platelets may reside in another Ca'+-initiated membrane event, such as reduced association of Ca2+ to one or more proteins that participate in cytoskeletal rearrange~nent.'~ Alternatively, we cannot ex- 
